Point72 Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Point72 Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-133,333	Closed	-$159K	–	2619
2023 Q4	$159K	Hold	133,333	–	–	﹤0.01%	1859
2023 Q3	$50.7K	Hold	133,333	–	–	﹤0.01%	2122
2023 Q2	$5.59K	Hold	133,333	–	–	﹤0.01%	1950
2023 Q1	$8.19K	Hold	133,333	–	–	﹤0.01%	2049
2022 Q4	$10K	Hold	133,333	–	–	﹤0.01%	1398
2022 Q3	$8K	Hold	133,333	–	–	﹤0.01%	1342
2022 Q2	$11K	Hold	133,333	–	–	﹤0.01%	1346
2022 Q1	$34K	Hold	133,333	–	–	﹤0.01%	1092
2021 Q4	$69K	Hold	133,333	–	–	﹤0.01%	1023
2021 Q3	$109K	Hold	133,333	–	–	﹤0.01%	980
2021 Q2	$136K	Hold	133,333	–	–	﹤0.01%	914
2021 Q1	$147K	Buy	+133,333	New	+$241K	﹤0.01%	892

Other funds holding TLSIW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Point72 Asset Management's TLSIW Position: Q1 2024 in Review

Point72 Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2024, closing a stake of 133,333 shares — an estimated $159K sold.

Point72 Asset Management first reported a position in TLSIW in Q1 2021 and held it in 12 quarters. The position peaked at $159K in Q4 2023. 21 funds tracked by Wall St. Rank hold TLSIW as of Q1 2024.

Point72 Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q1 2024 after selling out during the quarter.
Point72 Asset Management sold 133,333 TriSalus Life Sciences Warrant shares in Q1 2024, an estimated $159K.
Point72 Asset Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 12 quarters.
Point72 Asset Management's TriSalus Life Sciences Warrant position peaked at $159K in Q4 2023.
21 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.